New update. 16 months on finasteride, 25 year old, 1.25mg daily. The first picture is a screenshot from a video taken in February 2023, hence the quality is kinda poor.
    Progress Pictures 6/19/2024

    New to Finasteride? There is a guide in the encyclopedia. Read the guide β†’
    At a glance
    In this treatment experience post, the primary subjects mentioned are
    πŸ’Š Finasteride (oral) 1.25mg daily 16 months
    the tone is πŸ˜€ positive with noticeable results.

    Other terms

    A 25-year-old user shared progress pictures after 16 months of using 1.25mg daily finasteride for hair loss, reporting noticeable results around months 4-5 and some initial side effects that resolved. The user experienced thickening and slight regrowth of the hairline.
    View this post in the Community β†’

    Similar Community Posts Join

    6 / 6 results

    Related Research

    6 / 6 results
      Finasteride in Androgenetic Alopecia in Men

      research Finasteride in androgenetic alopecia in men

      June 2007 in “Advances in Dermatology and Allergology/PostΔ™py Dermatologii i Alergologii”
      This article discusses androgenetic alopecia in men and reports that finasteride at 1 mg/day for 24 months is generally well tolerated and may effectively inhibit hair loss.
      Systemic Treatment Options for Androgenic Alopecia

      research Systemic treatment options for androgenic alopecia

      March 2026 in “Lithuanian University of Health Sciences”
      In this study, a systematic review found that for androgenetic alopecia, systemic treatments like finasteride, dutasteride, and oral minoxidil are effective at slowing progression and promoting hair regrowth, with additional antiandrogen therapy options for women.
      The Inflammatory Component of Androgenetic Alopecia

      research The inflammatory component of androgenetic alopecia

      3 citations , November 2021 in “Journal of The American Academy of Dermatology”
      This article discusses hormonal mechanisms underlying androgenetic alopecia but does not report any new findings; it reviews the roles of dihydrotestosterone and available FDA-approved treatments.
      Updates in Treatment for Androgenetic Alopecia

      research Updates in Treatment for Androgenetic Alopecia

      January 2025 in “Annals of Dermatology”
      This review discusses current and emerging treatments for androgenetic alopecia, covering mechanisms, efficacy, and safety of both androgen-targeted and non-androgen-targeted approaches, but reports no new clinical results.